Latest Breaking News On - Manel cascall - Page 1 : comparemela.com

Theriva Biologics, Inc (NYSE:TOVX) Q3 2023 Earnings Call Transcript

Operator: Greetings, and welcome to the Theriva Biologics, Inc. 2023 Third Quarter Operational Highlights and Financial Results.

United statesManel cascalloVince wacherSteve shallcrossJames molloyManel cascallTheriva biologicsRicard mesiaWashington universityAlbumin shield technologyProduct development of theriva biologicsUniversity of pennsylvaniaCatalan institute of oncologyExchange commissionEuropean society for medical oncology annual congressAlliance global partners

Theriva Biologics, Inc (ASE:TOVX) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good morning, and welcome to the Theriva Biologics, Inc. 2023 Second Quarter Earnings Conference Call.

United statesComunidad autonoma de catalunaJames molloyChris calabreseManel cascallSteven shallcrossRamon alemanyVince wacherTheriva biologicsWashington universityVirotherapy groupAlliance global partnersProduct development of theriva biologicsCatalan institute of oncologyTheriva biologics incUniversity of leeds

Theriva Biologics (TOVX) Q3 2022 Earnings Call Transcript

Theriva Biologics (NYSE:NYSE:TOVX) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Chris Calabrese - Investor Relations Steven Shallcross - Chief Executive.

Frank tufaroVince wacherTheriva biologics europeChris calabreseTheriva biologicsManel cascallSteven shallcrossJim molloyExchange commissionCompany participantsProduct developmentAlliance global partnersProduct development of theriva biologicsConference call novemberChief financialSynthetic biologics

Synthetic Biologics (SYN) Announces Presentation at SIOP on New Preclinical Data Supporting Evaluation of VCN-01 and Topotecan for Treatment of Refractory Retinoblastoma

Synthetic Biologics (SYN) Announces Presentation at SIOP on New Preclinical Data Supporting Evaluation of VCN-01 and Topotecan for Treatment of Refractory Retinoblastoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesComunidad autonoma de catalunaVictor burgueManel cascallBarcelona international convention centerInternational society of pediatric oncologySynthetic biologics incWall streetSant joanInternational societyPediatric oncologyGeneral directorSynthetic biologic europeanGerm cell

Synthetic Biologics Announces Presentation at ESMO Congress 2022 Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck

Synthetic Biologics Announces Presentation at ESMO Congress 2022 Describing Phase 1 Investigator-sponsored Study Evaluating VCN-01 in Combination with Durvalumab in Patients with Recurrent/ Metastatic Squamous Cell Carcinoma of the Head and Neck
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesFrance generalComunidad autonoma de catalunaManel cascallChris calabreseLifesci advisorsSynthetic biologics incEuropean society for medical oncologySynthetic biologicsEuropean societyMedical oncologyGeneral directorSynthetic biologic europeanPhasei studyCombination with durvalumabSubjects with